Lipoxins are potential endogenous antiinflammatory mediators in asthma.
about
Resolution of inflammation in asthmaAspirin and decreased adult-onset asthma: randomized comparisons from the physicians' health studyLipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivitySpecialized pro-resolving mediators: endogenous regulators of infection and inflammationRoles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbuminResolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsCorticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma.The effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism.Innate immunity is a key factor for the resolution of inflammation in asthma15-lipoxygenase: a Janus enzyme?Novel therapies for the treatment of inflammatory airway disease.Asthma, airway biology, and nasal disorders in AJRCCM 2002.Physiological impact of abnormal lipoxin A₄ production on cystic fibrosis airway epithelium and therapeutic potential.Exhaled breath condensate in children: pearls and pitfalls.Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytesNew anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation?Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases?Helminths can protect themselves against rejection inhibiting hostile respiratory allergy symptoms.Lipid mediators as agonists for the resolution of acute lung inflammation and injury.Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study.Exhaled breath condensate eicosanoid levels associate with asthma and its severity.Diminished lipoxin biosynthesis in severe asthma.Chemical mediators and the resolution of airway inflammationModulation of obesity-induced inflammation by dietary fats: mechanisms and clinical evidence.Lipoxins: resolutionary road.The role of Lipoxin A4 in Cystic Fibrosis Lung Disease.Can metabolically healthy obesity be explained by diet, genetics, and inflammation?Serum amyloid A as a marker and mediator of acute coronary syndromes.Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes.Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.Serum levels of lipoxin A(4) do not predict the development of subsequent asthma among young children with acute bronchiolitis.
P2860
Q26823724-102EE39F-DFE2-472A-A25D-C437C7EA1446Q28201262-1E5B47B0-D17F-486A-A220-17AD29A236B9Q28221900-09CDB242-E990-42B0-BCFD-39CC4F7B9507Q28271331-81680607-B5F9-498C-ACD1-39B5DFCAFD42Q28394575-7C7D157B-7464-4F77-9B92-3959CA3F9AA8Q29615694-C8B8662F-4515-4268-92FB-EAC5021020C8Q30435721-0A3BC031-937E-4563-A58B-EDDF10992863Q33458930-40E9BA69-43F8-429F-9C79-80E4DD908016Q33882297-0D2A8C4A-13E4-4E7B-8437-13940C7B8942Q34422898-70FA21B9-E437-42CD-9C74-BC7065751132Q34465047-AD062C21-8AB8-43B5-8E9C-0808C688E3B9Q35005425-D2819116-711F-4170-8090-557C5BF044CDQ35040779-3BBDDA10-B280-4AED-8B7F-433C3E657CE3Q35055447-D5422984-EFAF-4CDB-A036-EA5826A1BE54Q35250351-DC0AB7DD-DEC1-4111-958B-896670646D24Q35681249-853AC0B5-7BEF-416C-8108-C277C0D0587DQ35734691-FB4C9A9D-D500-4AB5-A18F-E5E28B31838DQ35842492-1DBEF41A-CEDF-466D-AC6A-DF06A43D06EBQ35881906-85243547-B207-4919-8672-B45C2D2AB334Q35976385-CBD86C14-3846-4310-B84A-9205B478AE8EQ36411700-80979419-CC0F-4D85-9F7A-16B3F78F1565Q36600802-85C8BA6F-735C-45CA-8B37-705A10886B00Q37073991-E1C6D255-8D79-4966-9D67-0DCD7023E091Q37138368-84D01A5A-9CCC-448C-9DE1-5C09286F8AE2Q37282577-7C817EC2-9FED-4B2C-B739-5FBE41030B71Q37306353-213A84DC-09F1-46AA-AEC2-630F9BA9A011Q37579818-0C50F76D-E7FE-4ED3-8230-2935151F3FF7Q37604436-73C99477-926E-439A-B15C-682422C768A5Q37654922-689C36E9-3B74-4FCF-83E3-6A444E45CCC0Q38270746-A1113690-4A53-4E98-B2B7-A3673F955138Q39941673-074727C1-BE40-456D-BCF1-E4B7DDCCC92FQ41672237-C43DE07B-F082-456A-803F-9FBEFBA45B80Q42220886-5F6BB48C-2AD8-40F1-B305-15A41BDC417BQ51450614-8CDC880F-949B-4E65-8601-6EA99F4F62D3
P2860
Lipoxins are potential endogenous antiinflammatory mediators in asthma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Lipoxins are potential endogenous antiinflammatory mediators in asthma.
@en
Lipoxins are potential endogenous antiinflammatory mediators in asthma.
@nl
type
label
Lipoxins are potential endogenous antiinflammatory mediators in asthma.
@en
Lipoxins are potential endogenous antiinflammatory mediators in asthma.
@nl
prefLabel
Lipoxins are potential endogenous antiinflammatory mediators in asthma.
@en
Lipoxins are potential endogenous antiinflammatory mediators in asthma.
@nl
P2093
P1476
Lipoxins are potential endogenous antiinflammatory mediators in asthma.
@en
P2093
Caroline Bonnans
Claude Chavis
Jean Bousquet
Pascal Chanez
Philippe Godard
P304
P356
10.1164/RCCM.200201-053OC
P407
P577
2002-06-01T00:00:00Z